KRX/003220 (KRX/003220)

Korea Stock Exchange: KRX/003220 · KRW

₩7,760

+30.15 (+0.4%)· Recorded snapshot

Market cap	166.3B
Revenue (ttm)	614.6B
Net income (ttm)	2.6B
EPS (ttm)	₩110
Shares out	21.4M
P/E (trailing)	70.6x
P/E (forward)	11.1x
Dividend	₩250 (3.22%)
Volume	39,276
Beta	0.13

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 614.6B
Net income (ttm): 2.6B
EPS (ttm): ₩110
P/E (trailing): 70.6x
P/E (forward): 11.1x
Market cap: 166.3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E11.1

P25 7P50 11.1P75 20.3

Trailing P/E70.6

P25 7.2P50 12.6P75 23.6

ROE0.8

P25 -16.3P50 0.9P75 9.4

ROIC-0

P25 -9.5P50 1.6P75 7.2

Benchmarks · 1M

All KRX/003220 indicators

Market & fundamental data

Available fields

241

Groups with data

Currency

KRW

Showing 241 of 241 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	KRW
Country	South Korea
Country code	KR
Earnings date	2026-11-13
Employees	1,236
Enterprise value	KRW 297.3B
Exchange	Korea Stock Exchange
Financial currency	KRW
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1958
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	KR7003220001
Last earnings date	2025-11-13
Last refreshed	2026-10-28
Last stock split date	2022-03-07
Last stock split type	Forward
Market cap	KRW 166.3B
Next earnings date	2026-11-13
Price	KRW 7,760.00
Price currency	KRW
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	krx/003220
Website	https://www.daewonpharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	39.29x
Average P/E ratio (3Y)	25.37x
Average P/E ratio (5Y)	26.77x
Earnings yield	1.42%
EV/Earnings	112.97x
EV/EBIT	88.86x
EV/EBITDA	10.64x
EV/Sales	0.48x
FCF / EV yield	-1.74%
FCF yield	-3.11%
Forward P/E	11.14x
Graham number	5557.50522
Graham upside	-28.38%
Industry forward P/E	13.69x
Industry P/E	18.5x
Lynch fair value	KRW 2,747.86
Lynch upside	-64.59%
P/B ratio	0.6x
P/E ratio	70.6x
P/OCF ratio	9.15x
P/S ratio	0.27x
Price / tangible book value	0.82x
Price/EBITDA ratio	6.79x
Sector forward P/E	24.78x
Sector P/E	49.55x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-0.01%
EBITDA margin	3.99%
Effective tax rate	74.63%
Gross margin	45.48%
Operating margin	-0.01%
Pretax margin	1.47%
Profit margin	0.43%
Profit per employee	KRW 2.1M
Profitable quarters	3
Revenue per employee	KRW 497.3M
ROA	-0.01%
ROA (5Y)	3.37%
ROCE	-0.02%
ROE	0.83%
ROE (5Y)	5.65%
ROIC	-0.01%
ROIC (5Y)	5.15%
Tax / revenue	1.1%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-71.18%
EPS growth (QoQ)	64.98%
EPS growth 10Y	-17.92%
EPS growth 3Y	-35.29%
EPS growth 5Y	28.87%
EPS growth quarters	1
EPS growth years	0
Gross profit growth	-0.08%
Gross profit growth (Q)	12.34%
Gross profit growth 3Y	4.28%
Gross profit growth 5Y	11.36%
Net income growth	-67.76%
Net income growth (QoQ)	66.29%
Net income growth 3Y	-56.4%
Net income growth 5Y	31.97%
Net income growth quarters	1
Net income growth years	0
OCF growth	-77.3%
OCF growth 10Y	-0.9%
OCF growth 3Y	-15.71%
OCF growth 5Y	12.11%
Revenue growth	1.83%
Revenue growth (Q)	6.24%
Revenue growth (QoQ)	-3.31%
Revenue growth 10Y	10.34%
Revenue growth 3Y	6.99%
Revenue growth 5Y	14.24%
Revenue growth quarters	3
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	KRW -23.4B
Depreciation and amortization	KRW 24.6B
EBIT	KRW -87.9M
EBITDA	KRW 24.5B
EPS	KRW 109.91
FCF per share	KRW -241.29
Financing cash flow	KRW -7.7B
Free cash flow	KRW -5.2B
Gross profit	KRW 279.6B
Income taxes	KRW 6.8B
Investing cash flow	KRW -193.2M
Net borrowing	KRW 4.9B
Net cash flow	KRW 10.9B
Net income	KRW 2.6B
Operating income	KRW -87.9M
Revenue	KRW 614.6B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.26
Book value per share	KRW 12,488.86
Debt / EBITDA	7.72
Debt / equity	0.69
Interest coverage	-0.01
Long-term assets	KRW 339.8B
Long-term liabilities	KRW 89.7B
Net cash (debt)	KRW -123B
Net cash / market cap	-73.93%
Net debt / EBITDA	5.02
Net debt / equity	0.45
Piotroski F-Score	5
Property, plant and equipment	KRW 220.5B
Shareholders' equity	KRW 275.7B
Tangible book value	KRW 202.2B
Tangible book value per share	KRW 9,434.82
Total assets	KRW 573.3B
Total cash	KRW 66.2B
Total debt	KRW 189.2B
Total liabilities	KRW 297.6B
WACC	2.8%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.06
Current assets	KRW 233.6B
Current liabilities	KRW 207.9B
Current ratio	1.12
Inventory turnover	3.06
Net working capital	KRW 86.6B
Quick ratio	0.59
Working capital	KRW 25.7B
Working capital turnover	24.32

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-2.71%
Dividend growth	-16.67%
Dividend growth (10Y)	4.8%
Dividend growth (3Y)	-10.61%
Dividend growth (5Y)	11.06%
Dividend growth years	0
Dividend payment date	2026-04-24
Dividend payment years	26
Dividend payout frequency	Annual
Dividend per share	KRW 250.00
Dividend yield	3.22%
Ex-dividend date	2025-12-29
Last dividend	KRW 250.00
Payout ratio	203.58%
Shareholder yield	0.51%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-47.81%
10Y return CAGR	-4.79%
10Y total return	-38.81%
150-day SMA	KRW 8,763.67
15Y price change	157.91%
15Y return CAGR	7.98%
15Y total return	216.15%
1D price change	0.39%
1M price change	-1.15%
1M total return	-1.15%
1W price change	-1.27%
1W total return	-1.27%
1Y price change	-40.72%
1Y return CAGR	-39.5%
1Y total return	-39.48%
20-day SMA	KRW 7,863.00
200-day SMA	KRW 9,404.80
20Y price change	259.54%
20Y return CAGR	8.51%
20Y total return	412.15%
3M price change	0.13%
3M total return	0.13%
3Y price change	-49.77%
3Y return CAGR	-18.86%
3Y total return	-46.58%
50-day SMA	KRW 7,888.80
50-day SMA vs 200-day SMA	50under200
52-week high	KRW 13,670.00
52-week high date	2026-06-08
52-week low	KRW 7,060.00
52-week low date	2026-07-29
5Y price change	-51.11%
5Y return CAGR	-11.72%
5Y total return	-46.36%
6M price change	-29%
6M total return	-29%
All-time high	KRW 29,958.39
All-time high date	2020-07-24
All-time low	KRW 1,319.63
All-time low date	2008-10-27
Average true range (ATR)	KRW 268.86
Average volume	53.5K
Beta (1Y)	0.06
Beta (2Y)	0.1
Beta (5Y)	0.13
Change from 52-week high	-43.23%
Change from 52-week low	9.92%
Change from all-time high	-74.1%
Change from all-time low	488.04%
Change from open	-0.89%
Day's gap	1.29%
Dollar volume	KRW 304.8M
High price	KRW 7,870.00
Low price	KRW 7,750.00
Monthly RSI	25.07
Open price	KRW 7,830.00
Position in 52-week range	8.33%
Previous close	KRW 7,730.00
Price vs 150-day SMA	-11.45%
Price vs 20-day SMA	-1.31%
Price vs 200-day SMA	-17.49%
Price vs 50-day SMA	-1.63%
Relative volume	0.74
RSI	46.74
Sharpe ratio	-0.96
Sharpe ratio (3Y)	-0.66
Sharpe ratio (5Y)	-0.33
Sortino ratio	-1.44
Sortino ratio (3Y)	-0.87
Sortino ratio (5Y)	-0.39
Volume	39.3K
Weekly RSI	38.9
YTD price change	-35.06%
YTD total return	-35.06%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13M
Shares change (QoQ)	-0.75%
Shares change (YoY)	2.71%
Shares held by insiders	38.8%
Shares held by institutions	11.45%
Shares outstanding	21.4M

Deeper analysis on KRX/003220

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this KRX/003220 report

Is a complete KRX/003220 research report available?

No complete published report is available for krx/003220 (KRX/003220) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

KRX/003220 (KRX/003220)

Price

Financial snapshot

Fair-value bridge

Latest news · KRX/003220

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All KRX/003220 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on KRX/003220

Frequently asked questions